Truven Health Analytics
Truven Health Analytics Thursday introduced a new product, MarketScan Oncology Electronic Medical Records Database.
Truven Health Analytics announced the release of an addition to its Payment Integrity Enterprise solution: Provider Surveillance Executive Dashboards. The latest addition helps states and managed care organizations prioritize their provider credentialing workload by delivering public records information in an easy-to-consume format to root out healthcare fraud.
Two Michigan hospitals made the list of the 50 Top Cardiovascular Hospitals published by the health care information analysis firm Truven Health Analytics.
Truven Health Analytics and the Georgia Department of Community Health announced the launch of a statewide health information exchange network, the Georgia Health Information Network.
Truven Health Analytics announced today that its Meaningful Use Quality Manager version 2.0 is now compliant with the 2014 Office of the National Coordinator’s criteria for clinical quality measures reporting.
Truven Health Analytics has released Truven Health Action OI Practice Insights, software designed to help measure, benchmark and improve physician practice performance.
Truven Health Analytics announced the release of the latest version of its Micromedex Apple iPhone apps, giving current customers outside the United States and Canada on-the-go access to evidence-based clinical content for free.
Ann Arbor-based Truven Health Analytics has announced enhancements to its Truven Health Unify population health management system.
Truven Health Analytics Partners With Wakely Consulting Group To Help Health Plans Meet HHS Requirements
ANN ARBOR (WWJ) – Truven Health Analytics announced a partnership with Clearwater, Fla.-based Wakely Consulting Group to deliver a comprehensive set of products and services designed to help health plans comply with Affordable Care Act […]
Truven Health Analytics Poll Finds Opinions Split Between Cancer Patients, Non-Patients On High-Cost Drugs
Cancer patients may have a different point of view on oncology drug decisions than non-patients, according to a new poll conducted by Truven Health Analytics.